- Total Pro Portfolios with IART:
- BlackRock Health Sciences Instl SHSSX
- show more
- Total Do-It-Yourself Portfolios with IART:
- Chris Radigan
- Philip trucks Portfolio 1
- plinkster picks
- gsdomino Portfolio 1
- Cheap Growth Ready to Breakout: 3/14/07
- jddollar Portfolio 1
- telic
- huntp Portfolio 1
- arts285 Portfolio 1
- BENITRANS HV
- Cramer's 4 Strong Earnings Stock Picks
- BioSurgery
- nj4027
- show more
- 25
- Stem Cell Stocks
- Stu's Stocks
- Top Stem Cell Stocks
- Stockerblog.com Stem Cell Stocks
- GG Biotech Watch
- SOB starter
- turbopuppy Portfolio 1
- Stockerblog.com Largest Stem Cell Stocks
- nik's healthcare portfolio
- brian5s Portfolio 1
- Baby Teeth, Stem Cells, and Stocks
- PART 6 JPMorgan 27th Annual Healthcare Conf 1/14/09..3rd Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 30 08 |
|
3:30 |
|
Not yet rated
Rate now:
|
|
By:ctwilson57 |
Date:10 17 08 |
Competitor |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:06 18 08 |
P/E is 40, and the PEG is 1.01. |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:06 12 08 |
Finally, Cramer recommended Integra Lifesciences as a play on the aging U.S. population. Integra reported blowout earnings, beating estimates by 9 cents a share, or 22%. Yet the stock is only up 27 cents since it reported those numbers. |
|
Not yet rated
Rate now:
|
|
Date:02 13 08 |
|
All leading Presidential candidates support expanded stem cell research. While this is not a pure play on stem cells, it is part of the business model. |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:09 30 07 |
P/E is 47.12, the P/S is 2.57, and the PEG is 1.23. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by Banc of America Sec from Neutral to Buy |
|
Not yet rated
Rate now:
|
|
By:Pam |
Date:02 24 07 |
Integra Lifesciences Holdings (IART) This New Jersey company develops, manufactures, and sells medical devices, implants, biomaterials, and instruments to the neurosurgery, surgery, and soft tissue repair markets. P/E 45, P/S 3.4. |
|
Not yet rated
Rate now:
|
|
By:plinkster |
Date:01 09 07 |
medical device co. shows steady growth with a favorable population demographic |
|
Not yet rated
Rate now:
|
|
By:Stubonedoc |
Date:01 07 07 |
great tech in ortho |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:v771jr |
Date:12 04 07 |
Bad managenment |
|
Not yet rated
Rate now:
|
|



